Author

Matt Kane

Nanostring Technologies (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Adriana ZeeviiD· 1 shared Ansuman ChattopadhyayiD· 1 shared Brandon W. HiggsiD· 1 shared Chethan AshokkumariD· 1 shared Dhivyaa RajasundaramiD· 1 shared Divya Murali· 1 shared George Vincent MazariegosiD· 1 shared Kyle A SoltysiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adriana ZeeviORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Liver transplant rejection features memory cell priming, spatially differentiated networks and novel drug targets.

Mylarappa Ningappa, Chethan Ashokkumar, Divya Murali, Dhivyaa Rajasundaram, Brandon W. Higgs, William McDonald, Lori A. Schmitt, Liang Zhang, Ansuman Chattopadhyay, Matt Kane, Patrick Murphy, Kyle A Soltys, George Vincent Mazariegos, Shakti Gupta, Upendra K. Kar, , Rakesh K. Sindhi

The paper identifies molecular and spatial features of early liver transplant rejection, including primed T-cells, immune synapse activation, and novel drug targets like proteasomal and HSP90 inhibitors.

bioRxiv · Feb 4, 2025 · PreprintImmunology